Share

April 30, 2019; 92 (18) Patient Page

Can naproxen slow the progression of Alzheimer disease?About Alzheimer disease

Steven Karceski, Steven Karceski
First published April 29, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007418
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
309

Share

Article Information

vol. 92 no. 18 e2181-e2184
DOI: 
https://doi.org/10.1212/WNL.0000000000007418
PubMed: 
31036584
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 29, 2019.
Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Steven Karceski, MD
  1. Steven Karceski, MD
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

View Full Text

Article usage

Article usage: April 2019 to February 2023

AbstractFullPdfSource
Apr 20190748Highwire
May 201913212143Highwire
Jun 201957421Highwire
Jul 201916374Highwire
Aug 201914110Highwire
Sep 20194349Highwire
Oct 201963315Highwire
Nov 20196437Highwire
Dec 20194359Highwire
Jan 202022711Highwire
Feb 20200234Highwire
Mar 20201565Highwire
Apr 20204735Highwire
May 20202361Highwire
Jun 20203361Highwire
Jul 20208553Highwire
Aug 20201222Highwire
Sep 20201244Highwire
Oct 20200153Highwire
Nov 20201124Highwire
Dec 20201191Highwire
Jan 2021040Highwire
Feb 20210145Highwire
Mar 20210261Highwire
Apr 20210312Highwire
May 20212430Highwire
Jun 20211351Highwire
Jul 20211463Highwire
Aug 20210280Highwire
Sep 20211211Highwire
Oct 20210111Highwire
Nov 2021094Highwire
Dec 2021083Highwire
Jan 2022051Highwire
Feb 20220120Highwire
Mar 2022072Highwire
Apr 20223112Highwire
May 20221141Highwire
Jun 20220120Highwire
Jul 2022051Highwire
Aug 2022095Highwire
Sep 2022181Highwire
Oct 20220130Highwire
Nov 20220163Highwire
Dec 2022061Highwire
Jan 20231231Highwire
Feb 20230120Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me

Recommended articles